La XXV edición del Programa Farma-Biotech, que busca fomentar la investigación preclínica y traslacional, se ha centrado en esta ocasión en proyectos de Cataluña
Read moreImpurities in pharmaceuticals can compromise the safety, efficacy, and stability of a product. To safeguard public health, global regulatory authorities such as the International Council for Harmonisa...
Read moreThe study will evaluate the safety and efficacy of the molecule IMP1734, a selective inhibitor that blocks a key enzyme for DNA repair in cancer cells.
Read moreIt has been today announced that they has received “Decision to grant” communications from the Canadian Intellectual Property Office and the Israel Patent Office for its patent applications CA3071...
Read moreThe financial services company Inveready, a member of Catalonia.health, announces the successful closure of its life sciences fund Inveready Innvierte Biotech II. This is the second fund the firm has ...
Read moreHighlight Therapeutics and CNIO are collaborating to proof BO-112 effectiveness against the most common form of skin cancer, which is linked to sun exposure and is on the rise.
Read moreThe study, published in the journal Bioorganic Chemistry, identifies molecules capable of blocking a key interaction in the progression of this type of tumor.
Read moreIn pharmaceutical development, validating analytical methods goes further than regulatory formality. It is a critical component of ensuring reliable, reproducible, and scientifically sound data. The I...
Read moreBetween December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0 M from a capital increase, €7.0 M from commercial bank loans, €13.2 M from the EU-IPCEI grant...
Read moreOryzon Genomics, a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that the European Medicines Agency (EMA) has approved its Clinical Trial Application (...
Read moreThrough a series of well-established scientific assessments, ranging from toxicology assessments to pharmacokinetics and efficacy models, preclinical research generates essential data to support Inves...
Read moreAs drug candidates move from early research through commercial production, robust pharma quality control strategies become the backbone of safe, effective, and regulatory-compliant medicines. The inte...
Read more